Triple-negative breast cancer: histoclinical and molecular features, therapeutic management and perspectives, Bull Cancer, vol.100, issue.5, pp.453-64, 2013. ,
Recommandations françaises du Groupe Génétique et Cancer pour l'analyse en panel de gènes dans les prédispositions héréditaires au cancer du sein ou de l'ovaire, Bull Cancer, vol.105, issue.10, pp.907-924, 2018. ,
, Ministère de la Santé et des Solidarités. Plan national maladies rares, 2005.
Tuberculosis and impaired IL-23-dependent IFN-? immunity in humans homozygous for a common TYK2 missense variant, Sci Immunol. 21 déc, vol.3, issue.30, p.8714, 2018. ,
URL : https://hal.archives-ouvertes.fr/pasteur-02070591
Susceptibilité à l'obésité : rôle des déterminants génétiques des comportements alimentaires, Can J Diet Pract Res. déc, vol.78, issue.4, pp.197-203, 2017. ,
Driver and Passenger Mutations in Cancer, Annu Rev Pathol Mech Dis. 24 janv, vol.10, issue.1, pp.25-50, 2015. ,
Toward understanding and exploiting tumor heterogeneity, Nat Med. août, vol.21, issue.8, pp.846-53, 2015. ,
, Dépistage du cancer du sein en France: Identification des femmes à haut risque et modalités de dépistage, Laboratoires et consultations. 10. HAS, vol.34, 2014.
Coming of age: ten years of next-generation sequencing technologies, Nat Rev Genet. juin, vol.17, issue.6, pp.333-51, 2016. ,
, Selecting the best NGS enrichment assay for your needs
An Introduction to Next-Generation Sequencing Technology ,
, « Homogénéisation de l'interprétation de variants de séquence, p.22
Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results, Hum Mutat, vol.29, issue.11, pp.1282-91, 2008. ,
Estimations nationales de l'incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018. Synthèse, vol.20, 2019. ,
Épidémiologie du cancer du sein. EMC -Gynécologie, vol.7, pp.1-17, 2012. ,
Hallmarks of Cancer: The Next Generation, Cell. mars, vol.144, issue.5, pp.646-74, 2011. ,
, Recommandations INCa -femmes porteuses d'une mutation de BRCA1 ou BRCA2
La réparation de l'ADN, cible potentielle d'un développement thérapeutique en cancérologie, Bull Cancer, vol.21, 2006. ,
, Etude des predispositions génétiques aux cancers sein/ovaire
Prédisposition héréditaire au cancer du sein (2): Risques et prise en charge. médecine/sciences, avr, vol.35, issue.4, pp.332-377, 2019. ,
Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer, J Clin Oncol. 20 déc, vol.24, issue.36, pp.5652-5659, 2006. ,
Morphologic Features and Proliferation Indices of Breast Carcinoma Molecular Classes Using Immunohistochemical Surrogate Markers, vol.12, 2009. ,
, Cancer du sein triple négatif: histoire naturelle et étude des facteurs génétiques impliqués. Sciences du Vivant, 2018.
L'hématopoïèse clonale : un concept émergent à la croisée des spécialités, Rev Médecine Interne, vol.40, issue.10, pp.684-92, 2019. ,
Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer, J Clin Oncol. 1 févr, vol.33, issue.4, pp.304-315, 2015. ,
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing, JNCI J Natl Cancer Inst. 1 août, vol.110, issue.8, pp.855-62, 2018. ,
A study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genes: Panel Testing in Women With Breast Ca, Cancer. 15 mai, vol.123, issue.10, pp.1721-1751, 2017. ,
Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis. Medicine (Baltimore), vol.95, p.4975, 2016. ,
Germline breast cancer susceptibility gene mutations and breast cancer outcomes, Disponible sur, vol.18, 2018. ,
Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study, Lancet Oncol. févr, vol.19, issue.2, pp.169-80, 2018. ,
Clonal Hematopoiesis and therapy related MDS/AML, Best Pract Res Clin Haematol. mars, vol.32, issue.1, pp.13-23, 2019. ,
Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012), Breast Cancer Res Treat. janv, vol.119, issue.2, pp.391-399, 2010. ,
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes, N Engl J Med. 25 déc, vol.371, issue.26, pp.2488-98, 2014. ,
Prevalence of pathogenic BRCA1/2 germline mutations among 802 women with unilateral triplenegative breast cancer without family cancer history, 37. on behalf of the German Consortium for Hereditary Breast and Ovarian Cancer, vol.83, pp.105-117, 2018. ,
Impact of BRCA Mutation Status on Survival of Women With Triple-negative Breast Cancer, Clin Breast Cancer. oct, vol.18, issue.5, pp.1229-1264, 2018. ,